Outcomes in critically Ill HIV-infected patients between 1997 and 2020: analysis of the OUTCOMEREA multicenter cohort.

Acquired immune deficiency syndrome (AIDS) Antiretroviral therapy (ART) Human immunodeficiency virus (HIV) Intensive care unit (ICU) Outcome assessment

Journal

Critical care (London, England)
ISSN: 1466-609X
Titre abrégé: Crit Care
Pays: England
ID NLM: 9801902

Informations de publication

Date de publication:
13 03 2023
Historique:
received: 29 07 2022
accepted: 17 01 2023
entrez: 14 3 2023
pubmed: 15 3 2023
medline: 16 3 2023
Statut: epublish

Résumé

Despite antiviral therapy (ART), 800,000 deaths still occur yearly and globally due to HIV infection. In parallel with the good virological control and the aging of this population, multiple comorbidities [HIV-associated-non-AIDS (HANA) conditions] may now be observed. HIV adult patients hospitalized in intensive care unit (ICU) from all the French region from university and non-university hospital who participate to the OutcomeRea™ database on a voluntary basis over a 24-year period. Of the 24,298 stays registered, 630 (2.6%) were a first ICU stay for HIV patients. Over time, the mean age and number of comorbidities (diabetes, renal and respiratory history, solid neoplasia) of patients increased. The proportion of HIV diagnosed on ICU admission decreased significantly, while the median duration of HIV disease as well as the percentage of ART-treated patients increased. The distribution of main reasons for admission remained stable over time (acute respiratory distress > shock > coma). We observed a significant drop in the rate of active opportunistic infection on admission, while the rate of active hemopathy (newly diagnosed or relapsed within the last 6 months prior to admission to ICU) qualifying for AIDS increased-nonsignificantly-with a significant increase in the anticancer chemotherapy administration in ICU. Admissions for HANA or non-HIV reasons were stable over time. In multivariate analysis, predictors of 60-day mortality were advanced age, chronic liver disease, past chemotherapy, sepsis-related organ failure assessment score > 4 at admission, hospitalization duration before ICU admission > 24 h, AIDS status, but not the period of admission. Whereas the profile of ICU-admitted HIV patients has evolved over time (HIV better controlled but more associated comorbidities), mortality risk factors remain stable, including AIDS status.

Identifiants

pubmed: 36915207
doi: 10.1186/s13054-023-04325-9
pii: 10.1186/s13054-023-04325-9
pmc: PMC10012467
doi:

Types de publication

Multicenter Study Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

108

Informations de copyright

© 2023. The Author(s).

Références

J Acquir Immune Defic Syndr. 2010 Mar;53(3):397-404
pubmed: 19841589
Chest. 1991 Dec;100(6):1619-36
pubmed: 1959406
Am J Respir Crit Care Med. 2002 Aug 1;166(3):262-7
pubmed: 12153955
Intensive Care Med. 2014 Dec;40(12):1906-15
pubmed: 25236542
Crit Care Med. 2013 Jun;41(6):1458-67
pubmed: 23507717
Crit Care Res Pract. 2016;2016:2610873
pubmed: 27800179
Lancet. 2013 Nov 2;382(9903):1525-33
pubmed: 24152939
Int J Cancer. 2011 Jul 15;129(2):467-75
pubmed: 21207370
AIDS. 1999 Feb 25;13(3):415-8
pubmed: 10199233
Am J Transplant. 2019 May;19(5):1529-1535
pubmed: 30614612
N Engl J Med. 2015 Aug 27;373(9):795-807
pubmed: 26192873
J Acquir Immune Defic Syndr. 2010 Jul;54(3):248-57
pubmed: 20658748
J Acquir Immune Defic Syndr. 2013 Jan 1;62(1):52-9
pubmed: 23111572
JAMA Intern Med. 2013 Apr 22;173(8):614-22
pubmed: 23459863
MMWR Recomm Rep. 1992 Dec 18;41(RR-17):1-19
pubmed: 1361652
Lancet HIV. 2018 Sep;5(9):e524-e530
pubmed: 30025682
Intensive Care Med. 2020 Feb;46(2):329-342
pubmed: 32016535
Interdiscip Perspect Infect Dis. 2011;2011:847835
pubmed: 22121360
PLoS One. 2017 Oct 24;12(10):e0186968
pubmed: 29065165
Am J Respir Crit Care Med. 2011 Feb 1;183(3):388-95
pubmed: 20851926
Thorax. 2007 Nov;62(11):964-8
pubmed: 17517829
PLoS One. 2009;4(5):e5575
pubmed: 19440326
Gerontologist. 1970 Spring;10(1):20-30
pubmed: 5420677
Lancet. 2007 Apr 14;369(9569):1261-1269
pubmed: 17434401
J Clin Epidemiol. 2008 Apr;61(4):344-9
pubmed: 18313558
Crit Care Med. 2011 Aug;39(8):1886-95
pubmed: 21516036
Eur J Clin Microbiol Infect Dis. 2011 Sep;30(9):1085-93
pubmed: 21331480
Ann Intensive Care. 2012 Jul 04;2(1):25
pubmed: 22762133
Crit Care. 2010;14(3):R107
pubmed: 20534139
Curr HIV/AIDS Rep. 2019 Oct;16(5):404-413
pubmed: 31482298
Intensive Care Med. 1996 Jul;22(7):707-10
pubmed: 8844239
Int J STD AIDS. 2011 Sep;22(9):498-504
pubmed: 21890545

Auteurs

Antoine Gaillet (A)

Medical Intensive Care Unit, Henri Mondor University Hospital, APHP, 1 Rue Gustave Eiffel, 94010, Créteil Cedex, France. gaillet.antoine75@gmail.com.
IAME UMR 1137, INSERM, Paris University, 75018, Paris, France. gaillet.antoine75@gmail.com.

Elie Azoulay (E)

Medical Intensive Care Unit, Saint-Louis University Hospital, APHP, Paris University, 1 Avenue Claude Vellefaux, 75010, Paris, France.

Etienne de Montmollin (E)

IAME UMR 1137, INSERM, Paris University, 75018, Paris, France.
Medical Intensive Care Unit, Paris Diderot University/Bichat University Hospital, APHP, Paris, France.

Maité Garrouste-Orgeas (M)

Medical Unit, French-British Hospital Institute Levallois-Perret, Levallois-Perret, France.

Yves Cohen (Y)

Medical-Surgical Intensive Care Unit, Avicenne University Hospital, Paris Seine Saint-Denis Hospital Network, APHP, Bobigny, France.

Claire Dupuis (C)

Medical Intensive Care Unit, CHU Clermont-Ferrand, Clermont-Ferrand, France.
Nutrition Humaine Unit, INRAe, CRNH Auvergne, Clermont Auvergne University, 63000, Clermont-Ferrand, France.

Carole Schwebel (C)

Medical ICU, Albert Michallon University Hospital, Grenoble 1 University, Grenoble, France.

Jean Reignier (J)

Medical ICU, Nantes University Hospital, Nantes, France.

Shidasp Siami (S)

Polyvalent ICU, Sud Essonne Dourdan-Etampes Hospital, Dourdan, France.

Laurent Argaud (L)

Medical Intensive Care Unit, Hospices Civils de Lyon, Edouard Herriot University Hospital, Lyon, France.

Christophe Adrie (C)

Polyvalent ICU, Delafontaine Hospital, Saint-Denis, France.

Bruno Mourvillier (B)

Medical Intensive Care Unit, Reims University Hospital, Reims, France.

Stéphane Ruckly (S)

IAME UMR 1137, INSERM, Paris University, 75018, Paris, France.

Jean-Marie Forel (JM)

Medical ICU, Hôpital Nord University Hospital, Marseille, France.

Jean-Francois Timsit (JF)

IAME UMR 1137, INSERM, Paris University, 75018, Paris, France. jean-francois.timsit@aphp.fr.
Medical Intensive Care Unit, Paris Diderot University/Bichat University Hospital, APHP, Paris, France. jean-francois.timsit@aphp.fr.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH